SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-032661
Filing Date
2022-03-11
Accepted
2022-03-11 08:06:32
Documents
15
Period of Report
2022-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228957d1_8k.htm   iXBRL 8-K 38535
2 EXHIBIT 2.2 tm228957d1_ex2-2.htm EX-2.2 35126
3 EXHIBIT 99.1 tm228957d1_ex99-1.htm EX-99.1 21467
4 GRAPHIC image_001.jpg GRAPHIC 11865
  Complete submission text file 0001104659-22-032661.txt   301630

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA syn-20220310.xsd EX-101.SCH 3060
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220310_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220310_pre.xml EX-101.PRE 22614
9 EXTRACTED XBRL INSTANCE DOCUMENT tm228957d1_8k_htm.xml XML 3615
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 22731197
SIC: 2834 Pharmaceutical Preparations